Archives — April 2017 back to current month (50)
Lithium-ion batteries contain more cobalt than lithium, says Lior Gantz of the Wealth Research Group, and discusses the element's predicted shortage.
Technical analyst Jack Chan charts the latest moves in the precious metals market, including how changes in the USD could affect gold prices.
Avrupa Minerals, a prospect generator active in Europe, has closed a financing and announced that it has optioned the Alvito project in southern Portugal.
Maxim Group noted that data from Zynerba's Phase 2 proof of concept trial will be released in the third quarter; positive data would set the stage for Phase 3 trials.
Maxim Group recently initiated coverage of VistaGen Therapeutics, citing its progress on development of a fast-acting therapy to treat major depressive disorders.
Positive results in a Phase 1b trial of DURECT Corp.'s candidate for the treatment of nonalcoholic steatohepatitis (NASH), which were presented at the 2017 International Liver Congress, prompted comments from a pair of analysts.
Lumber Tariff Could Boost Canadian Gold Miners (04/26/2017)
The tariff the Trump Administration plans to slap on Canadian lumber imports should lead to a further weakening of the Canadian dollar, a move that precious metals expert Michael Ballanger says can only help the bottom line of Canadian gold producers.
AudioEye's innovative technology, which makes the internet available to people with disabilities, has led to rapid growth for the company.
Gold Is 1% Shy of Ripping Higher (04/24/2017)
Precious metals are on the verge of a legendary move, says Lior Gantz, editor of Wealth Research Group, and details the indicators he watches for.
Technical analyst Jack Chan charts upward trends in the precious metals markets.
Commercial production was declared at Red Eagle Mining's San Ramon mine in Colombia, nearly five months after announcing the first gold pour.
NexGen Drill Results Continue Expansion (04/20/2017)
Drill results from NexGen Energy's A3 Zone of the Arrow project have significantly expanded the zone to the northeast and have discovered massive pitchblende.
Exploration company Gold Standard Ventures has reported multiple results from its Dark Star prospect at its 100%-owned Railroad-Pinon project over the past week and a half.
The Small-Cap Biotech Watchlist, composed of 20 companies targeting a range of indications including blood cancers and solid tumors, irritable bowel disease and orphan diseases, has posted a modest gain since the first of the year.
Global Yields Worth Holding (04/19/2017)
Money manager Adrian Day reviews some of the companies in his portfolio, including some global companies with yields up to 7.5%.
Minaurum Gold Advancing Alamos Silver (04/19/2017)
Thibaut Lepouttre, editor of Caesars Report, profiles Minaurum Gold, which is developing the historic Alamos project in Mexico, and interviews geologist Peter Magaw, a director of the company.
Confusion Reigns. . . (04/19/2017)
Precious metals expert Michael Ballanger analyzes recent movements in the gold sector.
The Letter I Wrote George Soros About Gold (04/17/2017)
Gold is breaking out due to geopolitical concerns and continued conditions of negative real interest rates, says Lior Gantz, editor of Wealth Research Group.
How I Became a Multimillionaire at 33 (04/16/2017)
Tom Beck, senior editor of Portfolio Global Wealth, explains the investment strategy that was successful for him.
Technical analyst Jack Chan charts a reversal in the oil markets and outlines his strategy.
Technical analyst Jack Chan charts the completion of the gold marketís long correction.
Drilling at Fission Uranium's Patterson Lake South has confirmed the R1515W zone, and several analysts are expecting the resource to continue to expand.
Stars aligned for Golden Arrow when Chinchillas was ready to move to production and the company only had to look 18 miles down the road to Silver Standard's Pirquitas mine and its established production facility.
DNI Delivers Profitable Graphite (04/13/2017)
For Bob Moriarty of 321 Gold, the boom in demand for lithium ion batteries also means a boom in demand for graphite, and he is placing his bets on a junior he believes has nothing but blue sky ahead.
The purchase of Battle Mountain Gold gives Gold Standard Ventures another large project in one of Nevada's largest gold producing districts.
Positive results from RepliCel's Phase 1 trial for the treatment of aging and sun-damaged skin follow the release in the past few weeks of positive data from trials for chronic tendon problems and for hair loss.
The 4th annual AlphaNorth Capital Conference brought together over 40 emerging growth companies with top investors. In this interview with Streetwise Reports, Steve Palmer, founder and president of AlphaNorth Asset Management and a co-organizer of the conference, discusses a diverse group of companies that were selected to attend the conference, including three biotech companies.
With the granting of a new patent in Japan for its lead compound, RXI-109, RXI Pharmaceuticals has strengthened its reach in Asian markets and enhanced the protections surrounding its proprietary RNAi platform.
Rye Patch Restarts Florida Canyon Mine (04/11/2017)
As iA Securities initiates coverage on Rye Patch, the miner receives state approval to start irrigation at the new pad at its Florida Canyon mine.
Trump's Missile Strike on Syria and Gold (04/11/2017)
Technical analyst Clive Maund charts gold's movements following the U.S. missile attack on a Syrian airbase.
Trevali Mining Making All the Right Moves (04/11/2017)
Trevali keeps its eye on being THE "pure play" solution as it moves toward closing the agreement with Glencore International to acquire the Rosh Pinah and Perkoa zinc mines.
Daniel Ameduri, cofounder of Future Money Trends, shares the insights into gold investing he gained from a conversation with veteran investor and money manager Rick Rule.
Charts Spelling 'Big Trouble' for Silver (04/11/2017)
Silver's latest charts show that it is set up for a potentially severe decline, says technical analyst Clive Maund.
Lior Gantz of Wealth Resources Group discusses why he anticipates the majors will start making acquisitions of small-cap companies again and how investors can take advantage.
'Bond God' Jeff Gundlach Is Essentially Long Gold (04/09/2017)
Tom Beck, senior editor of Portfolio Wealth Group, examines how low real interest rates boost gold.
The Critical Investor profiles Leagold Mining, a company that just took over Goldcorp's Los Filos mine in Mexico.
Jack Chanís Weekly Gold and Silver Update (04/08/2017)
Technical analyst Jack Chan charts the latest developments in the gold and silver markets, including an all-time high in speculation in silver.
The release of NOVAGOLD's first quarter results has analyst Raj Ray of National Bank Financial highlighting that permitting for the Donlin Gold project is entering its final stage.
Klondex Ups Mineral Resource at True North (04/06/2017)
An updated mineral resource for Klondex's True North project that increases the Measured and Indicated resource by 32% and the Inferred by 45% caught the attention of several analysts.
Pershing Gold Climbs to the Next Level in Nevada (04/06/2017)
As Pershing Gold closes a deal to consolidate its Blackjack project, it continues to move the Relief Canyon mine closer to production.
Biotech may be the last great bastion of stock picking, posits Eden Rahim, who manages the Toronto-based Next Edge Bio-Tech Plus Fund. The fund is up 40% in the last 12 months. In this interview with The Life Sciences Report, Rahim provides his view of the sector and profiles four companies he believes may have great upside.
In a milestone for South San Francisco-based VistaGen Therapeutics, the European Patent Office (EPO) has issued a Notice of Intention to grant the company patents for its antidepressant prodrug, AV-101.
Zynerba Pharmaceuticals specializes in developing and commercializing synthetic cannabinoid therapeutics formulated for transdermal delivery. The Devon, Pennsylvania-based company's Q4/16 financial results disclose a substantial cash kitty of ~$78M available to fund its pipeline of medical marijuana products, ZYN001 and ZYN002.
Buy Precious, Sell Base (Metals). . . (04/05/2017)
Precious metals expert Michael Ballanger explains why he believes base metals are overbought and precious metals, especially silver, are set to appreciate.
An agreement that Torchlight Energy and its partner have signed with University Lands consolidates 192 existing leases in the Orogrande Basin project into one lease.
The Gold Report examined Victoria Gold's Eagle Project in February and is now checking in on the company's progress after two back-to-back news releases last week.
Inflation and War Are on the Horizon (04/02/2017)
Perhaps the final act is about to start for the global monetary system, says Kenneth Ameduri, chief editor of Crush the Street.com, and he discusses ways the precious metals can offer financial insurance.
Jim Rogers Is Bullish on Russia, and I Know Why (04/02/2017)
Tom Beck, editor of Portfolio Wealth Global, says if he's learned one thing in the markets, it is that Jim Rogers never misses a big long-term investment thesis, and that Rogers has basically told investors to "forget China, buy Russia."
Jim Rickards and I Are on the Same Page (04/02/2017)
Risks to the global economy was the main topic of the conversation between precious metals expert Jim Rickards and Lior Gantz, editor of Wealth Research Group.
Jack Chanís Weekly Gold and Silver Update (04/01/2017)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets.
|"We anticipate an NI 43-101 resource on RVG's Beartrack by mid-2018."|
|"DXD timeline to have a commercial product is much shorter than a traditional biotech company developing a new drug."|
|"PVG's Q4/17 operating and free cash flow were ahead of our estimates."|
|"Resources at FCU's Triple R deposit grew 34% to 140.6 Mlb U3O8."|
|"KBLT acquired a 1.75% NSR on all metals from the Dumont Ni-Co project."|